• Global Tip Location Devices Market is Estimated to be Valued at US$ 53.2 Mn by the End of 2026 - Tip location devices are being increasingly used for confirmation of PICC tip location during PICC insertion, owing to their advantages, such as meticulous precision and low-price. Tip location devices are emerging as a credible alternative to the more expensive methods used for PICC tip confirmation, such as X-ray and fluoroscopy. These factors are expected to fuel the growth of the US$ 27 Mn global tip location devices market, according to a new report by Future Market Insights (FMI). The report, titled, “Tip Location Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026”, projects 6.4% CAGR for the global tip location devices market during the forecast period 2016-2026. FMI’s report offers market forecast and analysis on the global tip location devices market, segmenting the market on the basis of product, technology, end-user, and region. North America Largest Market Globally According to FMI’s region-wise analysis, North America (U.S. and Canada) is the most lucrative market for tip location devices globally. The region accounted for 42.2% revenue share of the global tip location devices market in 2015, and is expected to increase at 7.1% CAGR during the forecast period, 2016-2026. Asia Pacific excluding Japan (APEJ), an emerging market for tip location devices, accounted for 8.0% revenue share of the market in 2015. On the basis of product, FMI’s report has segmented the market into tip location devices and accessories. The former dominates global revenues in terms of value, whereas the latter has higher market share in terms of volume. On the basis of technology, the tip location devices market has been segmented into ECG tip confirmation, ECG with magnetic tracking and ECG & intravascular Doppler. Tip location devices that use ECG & intravascular Doppler technology are expected to witness higher demand than devices that use only ECG technology and devices that use ECG with magnetic tracking. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-880 Key end-use sectors that generate the bulk of demand for tip location devices can be broadly categorised into hospitals, ambulatory surgical centres, and catheterization labs. Among these, hospitals account for the largest revenue share of the market, owing to increasing number of PICC insertion procedures carried out in hospitals. Drivers and Trends Increasing prevalence of chronic diseases, such as cancer, is leading to the rise in adoption of PICC procedures as PICC are used for administration of antibiotics, parenteral nutrition and for chemotherapy across the globe, which in turn is expected to fuel revenue growth of the tip location devices market globally over the forecast period. Cost-effectiveness offered by tip location devices in case of PICC tip confirmation as compared to X-ray and fluoroscopy and increased precision of PICC placement is further fueling revenue growth of the tip location devices market currently. Lack of clinical data regarding tip location devices and dearth of skilled professionals to operate the device are few factors expected to hamper growth of the global tip location devices market to a certain extent. Major trends in the tip location devices market include product modifications and innovations, strategic marketing campaigns and partnerships and acquisitions to increase consumer base. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-880 Analysis, by Region North America is expected to dominate the global tip location devices market and is projected to register a CAGR of 7.1% in terms of value over the forecast period. The tip location devices market in the U.S is expected to dominate the North America tip location devices market throughout the forecast period. The North America tip location devices market accounted for 42.2% revenue share of the overall market in 2015. The Japan market is projected to expand at a healthy CAGR of 6.1% during the forecast period. The APEJ market is estimated to account for 8.1% revenue share of the global tip location devices market by the end of 2016. Key companies profiled in FMI’s report include C.R. Bard, Inc., Teleflex Incorporated, AngioDynamics Inc., Vygon S.A. and CORPAK MedSystems (Added: Tue Jan 08 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Global Wearable Medical Devices Market 2026 - Global shipments of wearable medical devices will surpass 106 million in 2016, as rising awareness and disposable income continue to influence healthcare decisions. Global wearable medical device revenues are set to touch US$ 23,980.5 million, witnessing a y-o-y growth of 4.8% in 2016 over 2015. Increasing prevalence of diseases that require round-the-clock monitoring will continue to ramp up demand for wearable medical devices in 2016. Availability of compact, smartphone-compatible devices is also expected to boost adoption. Although average selling price of these devices is expected to witness a decline in 2016, high price still remains a key constraint for many patients. As technology makes further headway and competition become more intense, wearable medical devices are anticipated to become more affordable in the future. Wearable monitoring and diagnostic devices will continue to witness the highest demand in 2016, followed by wearable therapeutic medical devices. However, the latter will continue to account for higher revenues, owing to higher average selling price of these devices. Total shipments of wearable therapeutic medical devices are anticipated to reach 38,637,108 in 2016, representing market value worth US$ 14,543.6 Mn. Sleep apnea devices will continue to be the highest-selling wearable therapeutic medical device, with total shipments expected to reach 34,008,685 in 2016. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-826 Patient monitoring, home healthcare, and health & fitness will continue to remain the key end use application segments of wearable medical devices in 2016. Demand for wearable medical devices will be strongest in home healthcare segment, with total revenues expected to reach US$ 15,281.5 Mn in 2016. Wearable medical devices are gaining traction in the rapidly growing home healthcare sector, giving care providers and patients access to crucial physiological information. Clinics will continue to be the leading distribution channel for wearable medical devices in 2016. Clinics will sell US$ 7,717.0 Mn worth of wearable medical devices in 2016, up from US$ 7,348.4 Mn in 2015. Sales will continue to gain traction through online channels, with total revenues expected to reach US$ 4,669.0 Mn, a y-o-y increase of 4.6% in 2016 over 2015. North America will continue to be the largest market, followed by Western Europe and Asia Pacific excluding Japan (APEJ). The North America wearable medical devices market will reach US$ 9,608.7 Mn in 2016, up from US$ 9,143.2 Mn in 2015. Medtronic plc, Koninklijke Philips N.V., Sonova, and Fitbit Inc. are the leading players in wearable medical device market. Geographical expansion, investment in start-ups and SMEs remains the key business strategy of these players. Key Regions The global wearable medical devices market has been segmented into seven major regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). In terms of value, the North America market has been estimated to dominate the global wearable medical devices market in 2016, and is expected to witness highest CAGR of 7.4% over the forecast period. APEJ, Western Europe and Japan are estimated to be the fastest growing markets among regional markets. APEJ market is expected to expand at a CAGR of 7.0% over the forecast period. In North America, wearable monitoring and diagnostic device segment is expected to grow at faster rate to reach the value US$ 6,920.2 Mn by 2026 end. Market in MEA is expected to exhibit subdued market growth owing to lower adoption of wearable devices in the region. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-826 Key Players Some of the key players in the global wearable medical devices market include Medtronic plc, Siemens AG, Fitbit Inc., Bayer AG, Panasonic Corporation, Animas Corporation- Johnson and Johnson, Smiths Medical - A Smiths Group Company, Koninklijke Philips N.V., Owlet Baby Care, OMRON Corporation, Hoffmann-La Roche Ltd and Rest Devices Inc. Long-term Strategy: FMI projects the global wearable medical devices market to expand at 6.9% CAGR during the forecast period 2016-2026. (Added: Tue Jan 08 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• 29th International Conference on Nursing Practice - As Science is Dynamic and is continually evolving with new therapies on Horizon, within this field Nursing plays both as an art and as a science for caring the individuals suffering from untold pain physically and mentally. Allied Academies takes a pride to announce the 29th International Conference on Nursing Practice on July 8-9, 2019 at Prague, Czech Republic. A Gathering of experts to upgrade the practice of Nursing in Human Well-Being, our speakers and participants avail chances to learn and share their knowledge among their global peers. Benefits of participation at Nursing Practice 2019 The accepted abstract will be published in Journal of Intensive and Critical Care Nursing which will be provided with unique DOI number. Networking with Global Experts. Speaker and Abstract pages created in Google under your name will attract worldwide acknowledgment to your profile and research and it will be visible to 35K researchers across the globe. (Added: Tue Jan 08 2019 Hits: 4 Rating: 0.00 Votes: 0) Rate It

• Find Unsurpassed Services from Trusted Ultrasound Clinic in Gurgaon - Like any other tests, ultrasound is considered as one of the check-ups that is advised by the doctor on serious note when it is required. The scan can be performed due to medical and pregnancy reasons. This is the safest and easiest technique if done by the experienced radiologist like Dr. Anmol Sethi who is also running an Ultrasound Gurgaon clinic. At Dr. Anmol’s Ultrasound Clinic, you can have as many as ultrasound scan but it should be mentioned in prescription by the doctor. The center is known for providing the varied ultrasound test in the midst of pregnancy and for gynaecology. They assure to provide with the most noteworthy services and care for all of the patients.
  This clinic has earned a great reputation since its inception till now. Its labs are well-built and equipped with the latest machines in ultrasound technology, GE Voluson E8 that are used to conduct an ultrasound at ease. Our clinic is designed to keep you relaxed and comfortable. We conduct a regular internal audit to ensure quality control. We follow a quality control checklist for all cleaning and handling procedures. Our clinic is built to keep you stress-free and agreeable. We perform an ordinary interior review to guarantee quality control. We pursue a quality control agenda for all cleaning as well as dealing with techniques. They have approachable and understanding staff who take your well-being as well as the experience you have at the clinic genuinely. It is exceptionally fundamental to have such staff since it is the way to make the customer feel very much secure.
  The clinic is ideally known for having level 2 ultrasound in Pregnancy. A qualified and experienced doctor, who has obtained the ability to do as such does this. It is normally carried out between 18-22 weeks of pregnancy so as to identify fetal anomalies that may have personal satisfaction and provides the parents with options for treatment or end of the pregnancy. It is likewise called an Anomalies Scan or a Targeted Investigation for Fetal Anomalies. In India, the MTP act does not permit terminations after 20 weeks and, in this way, the level II study is done at 19 weeks of pregnancy. The weeks are checked from the start day of the last menstrual period. Level 2 ultrasound has incredible importance. It is liable for discovering kind of growing, and moreover, hereditary disorders in the child Down syndrome, trisomy 18, trisomy 13 are one of these disorders. So, if your doctor has asked you for level 2 ultrasound, then visit here and get affordable yet quality services.
  E-mail docanmol@yahoo.com
  phone no. 9871371100
  https://dranmolsethi.com/ultrasound/level-2-ultrasound/ (Added: Tue Jan 08 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Genetic Testing Services Market is Driven by the Adoption of Genetic Testing by Physicians - The global genetic testing services market is expanding with the increasing incidence of cancer and rare as well as autoimmune diseases. The global genetic testing services market was valued at US$ 33,500.0 Mn in 2016 and is projected to register a compounded annual growth rate (CAGR) of over 7.6% from 2017 to 2025, to reach value of US$ 64,131.0 Mn by 2025. The global market is witnessing relatively high growth, owing to increase in awareness among people, adoption of genetic testing by physicians and patients, and rise in the prevalence of chronic diseases across the globe. Read Report Overview: https://www.transparencymarketresearch.com/genetic-testing-services-market.html Genetic test is a type of medical test which analyzes the changes in chromosomes, proteins, or genes, which may be caused by any suspected genetic condition or disease. Genetic testing is also performed on tumors to diagnose cancer and plan the treatment. Several genetic tests are used currently. The key types of genetic testing are newborn screening, prenatal testing, pre-implantation testing, carrier testing, etc. Several methods such as molecular method, chromosomal method, and biochemical method can be used for genetic testing. Genetic testing is employed to identify the risk factors, to screen the newborns, and also in forensics. The global genetic testing services market is witnessing significant growth and is expected to expand at a robust CAGR during the forecast period. Rise in the adoption of health care IT solutions for genetic testing, increase in the prevalence of cancer and cardiovascular diseases, and benefits offered by genetic testing (such as specificity and early identification) are expected to have a positive impact on the global genetic testing services market during the forecast period. Furthermore, rising awareness about genetic services and increasing incidence of common autoimmune diseases are likely to propel the global genetic testing services market during the forecast period. Lack of awareness about genetic services in several developing regions and high cost of genetic tests in several countries are a few of the factors restricting the global genetic testing services market. The global genetic testing services market has been segmented based on test type, service provider, application, and geography. Based on test type, the market has been segmented into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing, and others. Among these, the predictive & presymptomatic testing segment held a major market share, in terms of revenue, in 2016. Increase in awareness about diseases such as cancer and early detection of diseases are some of the factors fueling the segment. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10235 Based on service provider, the global genetic testing services market has been classified into hospital-based laboratories, diagnostics laboratories, specialty clinics, and others. The hospital-based laboratories segment held the largest share of the market in 2016, in terms of revenue, followed by the diagnostic laboratories segment. User convenience and increasing number of hospitals are a few factors projected to propel the hospital-based laboratories segment during the forecast period. Based on application, the global genetic testing services market has been divided into oncology, infectious diseases, autoimmune diseases, and others. The oncology segment is anticipated to dominate the market during the forecast period, due to high prevalence of cancer across the world. Geographically, North America dominates the global genetic testing services market, followed by Europe. Developed countries such the U.K., the U.S., and Germany witness more awareness about genetic testing. Furthermore, developed infrastructure, increase in health care investments, and robust R&D activities in these countries are driving the market in these countries. The market in the Asia Pacific region is expanding rapidly. Developed countries in the region such as Australia and Japan are offering growth opportunities to the genetic testing services market. India and China are potential markets for genetic services, due to increase in the prevalence of infectious diseases in these countries. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10235 Some of the key players operating in the global genetic testing services market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics, Hoffmann-La Roche Ltd, Illumina, Inc., CENTOGENE AG, and 23andMe, Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Patient Handling Equipment Market: High Risk of Injuries to Caregivers to Drive Demand - The demand in the global patient handling equipment market is projected to increment at a robust CAGR of 10.4% during the forecast period of 2017 to 2024, gaining traction from a number of factors such as rising geriatric population, high risk of injuries to caregivers as well as the patients during manual handling, increasing incidence of disabilities, and implementation of regulations pertaining to the safety at the healthcare facilities. On the other hand, the lack of skilled professionals to handle these equipment is hindering the market from attaining its true potential. Nevertheless, the vendors operating in the global patient handling equipment market are expected to gain new opportunities from private institutional nursing and the entry of several major players in domestic markets. Read Report Overview: https://www.transparencymarketresearch.com/patient-handling-equipment-market.html As per the estimations of the report, the global patient handling equipment market will be worth US$22.4 bn by the end of 2024, significantly up from its evaluated valuation of US$11.2 bn in 2017. The healthcare industry is currently flourishing in a number of developed and emerging economies, and if the vendors operating in this market can formulate a way to train professionals to operate these equipment, the demand will be ideally met. Based on product-type, the market for patient handling equipment has been segment into wheelchairs, lifting slings, medical beds, ambulatory aids, and shower, bath, and toileting equipment. In 2017, medical bed segment was most profitable, and considering they are mandatory equipment for the caregivers and are readily invested on by the hospitals, the segment is expected to remain the most important throughout the forecast period. Moreover, a number of high-end super-specialty healthcare facilities are coming up, which are willing to invest on the latest products that enable their patients in bathing, walking, and toileting. Financially equipped patients in the urban parts of the world are also driven towards hospitals with modern facility, and thereby providing traction to the medical bed segment of the global patient handling equipment market. Curative care beds, long-term care beds, and psychiatric care beds are some of the sub-segments of the medical beds that are gaining demand across the world. From geographical perspective, some of the most important regions for the patient handling equipment market are North America, Europe, and Asia Pacific. Among these, Europe held the leading position in 2017, and is likely to retain its top position throughout the forecast period, owing to robust healthcare infrastructure and government regulations in respective countries. By 2024, the Europe patient handling equipment market is estimated to be worth US$8.0 bn. On the other hand, the region of Asia Pacific, which resides some of the most promising emerging economies such as India, China, and Japan, are expected to turn into highly lucrative region towards the end of the forecast period. Growing popularity of medical tourism is also expected to favor the added demand for patient handling equipment from Asia Pacific. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6577 ArjoHuntleigh (Getinge Group) is identified as the most prominent company currently operating in the global patient handling equipment market, although the report also picks out a few other notable players, such as V.Guldmann A/S, DJO Global, Hill-Rom Holdings, Inc., Invacare Corporation, Etac AB, Joerns Healthcare LLC, Permobil AB, Prism Medical, Stiegelmeyer & Co. GMBH, Stryker Corporation, Patterson Medical Holdings, Inc., and Sunrise Medical LLC. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/a (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Emergency Medical Equipment Market Trends & Forecast to 2026 - Emergency medical equipment is an integral part of health care systems. It comprises specialized equipment and products to aid in the provision of emergency care. Severe physical injuries such as trauma and medical emergencies such as cardiac arrest are life threatening and require quick medical attention. Thus, a rise in the incidence of trauma injuries and other medical emergencies creates lucrative opportunities for the emergency medical equipment market. As per the U.S. American Association for the Surgery of Trauma, around 3 million non-fatal injuries occurs each year in the U.S, which lead to over 150,000 deaths. Improving hospital care facilities, rise in demand for emergency medical equipment, and increase in government expenditure are anticipated to drive the global emergency medical equipment market. However, high price of emergency medical equipment and product recall due to improper functioning are expected to hinder the growth of the market during forecast period. Read Report Overview: https://www.transparencymarketresearch.com/emergency-medical-equipment-market.html The global emergency medical equipment market can be segmented based on type, application, end-user, and geography. Based on type, the global emergency medical equipment market can be classified into wound care consumables, patient handling equipment, emergency resuscitation equipment, infection control supplies, patient monitoring systems, personal protection equipment, and others. The emergency resuscitation equipment segment is expected to hold a significant share of the market during forecast period, owing to a rise in in the number of emergency visits and increase in demand for emergency resuscitation equipment. In terms of application, the global emergency medical equipment market can be categorized into trauma injuries, cardiac care, respiratory care, and other applications. The cardiac care segment is expected to account for a significant share of the market during forecast period, due to high incidence of cardiac diseases and rise in geriatric population prone to cardiac diseases. Based on end-user, the global emergency medical equipment market can be classified into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment is anticipated to dominate the market during forecast period due to developments in hospital infrastructure, rise in the number of hospital visits and hospital stays, and increased government spending on health care facilities. In terms of geography, the global emergency medical equipment market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to hold a significant share of the market, followed by Europe. High incidence of trauma injuries, rise in the number of emergency visits, strong presence of key players, technological advancements, and well-established hospital infrastructure are estimated to propel the emergency medical equipment market in North America and Europe. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The market is likely to be driven by India and China, owing to significant emergency visits by patients, rise in geriatric population prone to medical emergencies, increased government funding, and developing hospital infrastructure. The market in Latin America and Middle East & Africa is anticipated to expand at a sluggish pace during the forecast period, owing to high cost of emergency medical equipment and lack of proper health care facilities and skilled manpower. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53445 Leading players operating in the global emergency medical equipment market include GE Healthcare, Stryker, Asahi Kasei, Medtronic, Cardinal Health, Philips, 3M, Smiths Medical, Smith & Nephew, Becton, Dickinson, Johnson & Johnson, and B. Braun. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Clinical Pediatrics 2019 - Clinical Paediatrics 2019 welcome you all to attend the 2nd World Congress on Paediatrics and Clinical Paediatrics, which is going to be held at Edinburgh, Scotland from June 12-13, 2019. The main theme of the conference is Late trends and Formative Assessments in Clinical Paediatrics. This conference contains various sessions like speaker presentation, poster presentation, video/oral presentation, E-poster presentation, workshops and seminars. We cordially welcome, all the Students, Doctors, Professors, Researchers, Business Delegate, Media Partners, Collaborators, and sponsors towards Clinical Pediatrics 2018 Conference. (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Best and Reliable Service Provider Global Air Ambulance Service in Gaya - January 07, 2019 - Global Air Ambulance, A company that works for the welfare of the people who are serious, critical, or highly injured. Yesterday it came with good news for the sake of poor or middle-class patients family the news is that it is going to provide the best service to the Gaya and Indore people with newest and highly equipped medical types of equipment and it also announced that it will provide every medical type of equipment at manageable cost. Know it will also allow one or two relatives of the patient to board the air ambulance at no extra cost. Also, there is no hidden cost levied on the customer at any stage of the patient evacuation. This Air Ambulance provides all advanced and basic life-saving equipment’s in an affordable range to secure patients life. This air ambulance is the most-exclusive and well-occupied service provider. Global Air Ambulance in Gaya provides emergency services with bed-to-bed transfer service from one city to another city and all over in India with all basic and advanced life-saving setups. This Air Ambulance Service provides the bed to bed service to the injured patient from one city to another city. Global Air Ambulance Gaya provides top MD Doctors and paramedical technicians and Medical Charted Aircraft with all advanced and hi-tech set-ups to save patient’s life and also bed to bed service from one city to another city.              Global Air Ambulance from Indore one of the best health care service providers to the needy and injured patients. Our medical teams are 24/7 hours available for the help of the injured patients and also provide the bed to bed service from one city to another city. Web@ https://www.globalairambulance.in/air-ambulance-services-in-indore/ (Added: Mon Jan 07 2019 Hits: 7 Rating: 0.00 Votes: 0) Rate It

• Global Cataract Surgical Devices Market to cross US$ 8.5 Billion by 2023 - The global cataract surgical devices market has experienced a moderate growth, over the recent years. Some of the factors which are providing impetus to the market include constant support from the government, changing lifestyles, rise in geriatric population and technological advancements. Cataract refers to the clouding of the eye’s lens which results in the blurring of the vision. It develops gradually and may affect one or both the eye. Some of the symptoms of cataract include colour fading, blurring vision, appearance of halos near lights, discomfort due to bright lights, night blindness, etc. Cataract cannot be rectified with contact lenses or glasses and only a surgery can eradicate the clouded lens by replacing it with an artificial lens. A new research report by IMARC Group, titled “Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” estimates that the global cataract surgical devices market was worth US$ 6.8 Billion in 2017. The report further anticipates the market to cross US$ 8.5 Billion by 2023, at a projected CAGR of 3.8% over the forecast period. Browse full report with complete TOC: https://www.imarcgroup.com/cataract-surgical-devices-market (Added: Mon Jan 07 2019 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Rhino’s Gym Opens Club at Naraina To open 20 Franchise Gymnasium’s in the First Year - New Delhi, 7th January 2019: Mr Harmeet Singh Luthra, Managing Director, Rhino’s Wellness, today announced the opening of Rhino’s Gym India’s second club in Naraina at New Delhi. Spread over 3400 square feet and located at B-192, Industrial Area Phase I, Block B, Naraina Industrial Area Phase 1, Naraina, New Delhi, Delhi, the Gym comes replete with the latest Gymnasium equipment’s including Treadmills, Cross Trainers, experienced instructors. While announcing the launch Mr. Harmeet Singh Luthra, Founder Rhino’s Gym India said “Naraina and Paschim Vihar is just the start, we at Rhino’s Gym plan to open more than 20 Outlets in the 1st year Itself. We will guarantee not just World Class Support, but our proven concepts and easy process’s will offer Gym owners the Fastest Return on Investments (ROI) in the Industry”. The Gymnasium has ACE (American Council on Exercise) certified general and personal trainers also offering Cardio Training, Strength Training, Functional Training along with, Aerobics, Zumba, Yoga, & Meditation. “The Rhino’s Gym India concept is a purely Indian concept, designed to specifically suit the Indian conditions pockets and requirements. We will soon have Rhinos Gyms opening at Ranchi (Jharkhand) Andheri East (Mumbai) and 3 more in New Delhi” further added Mr Luthra. Mr Luthra, has experience in establishing more than 8000 Gymnasiums across India. The clubs across India will also have on offer personalised ergonomic training, especially for older people since this is the age when one needs more focus on fitness. Providing elite and functional fitness clubs that are highly profitable with super quick Return on Investments, the management of Rhino’s Gym aims to help develop a project which not only focuses on the service that is being delivered to your club’s members but also ensures great and beyond expectations faster returns to its franchises. About Rhino’s Gym India Rhino’s Gym India was founded in early 2018 by people with experience of setting more than 9000 Gymnasiums across India. The aim of the chain is to provide highly profitable, elite and functional Fitness clubs across India. The chain has been powered by powered by the Fitline group that have been serving the fitness industry since 23 years. For further details please visit www.rhinosgym.in (Added: Mon Jan 07 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Medical Tubing Market Forecast to 2026 Insights Shared in Detailed Report - Heart failure is a medical condition caused due to abnormal cardiac structure and function. Heart failure is a chronic progressive disorder that affects blood pumping capacity of the heart muscles, leading to insufficient supply of blood to the whole body. Systolic heart failure and diastolic heart failure are the two main types of heart failure. In systolic heart failure, the left ventricle of the heart fails to contract normally, while in diastolic heart failure, the muscles in the left ventricle become stiff. Common symptoms of heart failure include fatigue, swelling at the ankles, feet, and legs, weight gain, and increased urge to urinate. Heart failure has significant burden on the global health care system, affecting more than 26 million people across the globe. It is estimated that heart failure across the globe had cost around US$ 100 Bn in 2012. Read Report Overview: https://www.transparencymarketresearch.com/heart-failure-therapeutics-market.html The global heart failure therapeutics market is estimated to be primarily driven by high incidence rate of heart failure disorders across the globe. Around 5 million Americans are estimated to be currently living with congestive heart failure and more than 5.5 million new cases are diagnosed every year in the U.S. Also, heart failure cases account for 11 million visits to physicians every year in the U.S. and higher number of hospitalization than that of all forms of cancer combined together. Moreover, adoption of western lifestyle, lack of physical exercise, daily life stress, unhealthy diet, and high prevalence of obesity are the key causes leading to heart failure. These factors are projected to fuel the growth of the global heart failure therapeutics market during the forecast period. Rise in trend of new product development and commercialization among the leading players operating in the global market has been observed since the past few years. Increase in demand and easy availability of heart failure therapeutics drugs are estimated to drive the growth of the market during the forecast period. The global heart failure therapeutics market can be segmented based on heart failure stage, drug class, distribution channel, and region. In terms of heart failure stage, the market can be classified into class I, Class II, Class III, and Class IV. Based on drug class, the market can be divided into Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Diuretics, Beta Blockers, Procoralan, Mineralocorticoid Receptor Antagonists, and others. Angiotensin-converting enzyme (ACE) inhibitors are a group of medication used for dilation or widening of heart blood vessels to facilitate the free flow of blood to the heart and to lower the blood pressure. Most commonly used ACE inhibitors include Accupril, Aceon, Altace, Capoten, Lotensin, Mavik and Monopril. ACE inhibitors are generally prescribed for management of high blood pressure, heart failure, coronary artery diseases, diabetes, and other cardiovascular disorders. The ACE inhibitors segment is projected to dominate global heart failure treatment market by the end of 2026, expanding at a significant CAGR during the forecast period. In terms of distribution channel, the market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is poised to hold prominent share of the market by the end of 2026. In terms of region, the global heart failure therapeutics market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are estimated to account for a dominant share of the global market, owing to high prevalence and rise in incidence rate of heart failure, large base of pharmaceutical companies, high awareness level, well-established health care facilities, and favorable medical reimbursement policies in these regions. Moreover, rapidly increasing geriatric population which is more prone to suffer from heart failure in countries such as the U.S., the U.K., Germany, and France is likely to contribute to major market share of these regions by the end of 2026. The heart failure therapeutics market in Asia Pacific is projected to grow rapidly during the forecast period, owing to large pool of patients affected with heart failure in highly populous countries such as India and China, large base of geriatric population in Japan, and rapidly changing health care sector in the emerging countries. Increase in per capita health care expenditure, rapidly growing biopharmaceutical industry, and various initiatives taken by the government in the emerging countries to promote health care are estimated to fuel the growth of the heart failure therapeutics market in Asia Pacific during the forecast period. The heart failure therapeutics market in Latin America and Middle East & Africa is projected to grow at a moderate rate during the forecast period. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53994 The global heart failure therapeutics market is highly fragmented. A large number of manufacturers holds prominent market share in respective regions. A key trend of mergers and acquisitions and new product development among the leading players has been observed since the past few years. Companies are engaging in mergers and acquisitions in to order to strengthen their product portfolio and enhance their geographic presence in respective regions. Key players operating in the global heart failure therapeutics market include Amgen Inc., Pfizer Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Abbott, Bayer AG, Orion Corporation, Merck & Co. Inc., and Cardiorentis Ag. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Acetazolamide Market-Global Industry Insights And Trends - The global acetazolamide market size was valued at US$ 183.2 Mn in 2017, and is expected to witness a CAGR of 4.8% during the forecast period (2018 – 2026). Acetazolamide is carbonic anhydrase inhibitor, used in adjuvant treatment of chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma, epilepsy, edema due to congestive heart failure, drug-induced edema, and acute mountain sickness in climbers. Acetazolamide promotes acclimatization to altitude, increases bicarbonate secretion by the kidneys, induces metabolic acidosis, and stimulates ventilation. Furthermore, according to the BMJ Journal, September 2012, acetazolamide in doses of 250 mg, 500 mg, and 750 mg daily are more effective compared to placebo for preventing acute mountain sickness. In addition, acetazolamide 250 mg daily is the lowest effective dose to prevent acute mountain sickness. Acetazolamide is used to prevent high altitude illness in most people, which is characterized by headache, nausea, vomiting, and tiredness (often called acute mountain sickness), but may affect the brain or the lungs in different individuals. As per the study published in Cochrane Journal, in June 2017, acetazolamide is an effective and better treatment for the prevention of acute high altitude illness (HAI) in dosages of 250 to 750 mg/day, when compared to a placebo. Acetazolamide prevents acute mountain sickness and has fewer side effects than alternative drugs such as dexamethasone. According to BMJ journal, May 2018, prescribing acetazolamide for travel is an optional service and not included in the general practitioner’s contract in the U.K. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2396 Researchers at the University of Chicago investigated acetazolamide, and published in the journal Science Translational Medicine, July 2018, stating that, altitude sickness drug, acetazolamide, helps to overcome resistance to chemotherapy drug temozolomide (TMZ). TMZ is frequently used in the treatment of gliomas, but some patients do not respond to the treatment. With the addition of acetazolamide, researchers identified an improvement in survival rates, in pre-clinical models of glioma. According to this study, acetazolamide when taken with TMZ, resulted in 30 to 40 percent increase in survival in animal models. Application of acetazolamide could be used as an alternative treatment solution for reducing resistance to chemotherapy in the treatment of gliomas, which offer lucrative growth opportunities for the drug in the market in the near future. Furthermore, along with chronic simple (open-angle) glaucoma, secondary glaucoma and acute mountain sickness in climbers; acetazolamide is also indicated for adjective treatment of edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies. Increasing prevalence of glaucoma and associated risk factors such as high myopia, diabetes, eye surgery or injury, high blood pressure, increased usage of corticosteroids, and family history of glaucoma among the global population are expected to offer conducive future growth for acetazolamide drug manufacturers. As a sustained release capsule of Acetazolamide taken a day, offers a substantial pressure-lowering effect that lasts at least 23 hours. Treatment with acetazolamide helps to reduce eye pressure, which aids in preventing eye damage. Acetazolamide works by blocking the action of an enzyme called carbonic anhydrase thereby, reducing the amount of fluid secreted in the front part of eye, thus lowering eye pressure. For instance, according to the study published in the Journal of Ophthalmology (2014), an estimated 64.3 million people (aged 40-80 years) in 2013, were affected with glaucoma, which would increase to 76.0 million in 2020, and 111.8 million in 2040. According to the International Agency for the Prevention of Blindness, 2017, glaucoma is the second leading cause of blindness and leading cause of irreversible blindness worldwide. With primary angle closure glaucoma (PACG) being the most common in South-East Asia while primary open-angle glaucoma (POAG) is mostly found among white Caucasians and individuals of Africa. Among region, Asia Pacific is expected to be conducive region for the acetazolamide market growth. This is mainly owing to growing healthcare infrastructures, high prevalence of glaucoma, and associated risk factors such as diabetes and high blood pressure cases among the population of the region. For instance, according to American Academy of Ophthalmology (AAO), November 2013, glaucoma is the most common cause of preventable, irreversible blindness worldwide, among which primary open-angle glaucoma (POAG) is responsible for 12.3% of blindness. Furthermore, according to same source, POAG’s prevalence is estimated to be the highest among the people of China, intermediate in Japan, and lower in Europe and India. Therefore, these driving factors are expected to propel growth of acetazolamide market in Asia Pacific. Click To Reading More On Acetazolamide Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Mon Jan 07 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Heart Failure Therapeutics Market Trends and Forecast to 2026 - Heart failure is a medical condition caused due to abnormal cardiac structure and function. Heart failure is a chronic progressive disorder that affects blood pumping capacity of the heart muscles, leading to insufficient supply of blood to the whole body. Systolic heart failure and diastolic heart failure are the two main types of heart failure. In systolic heart failure, the left ventricle of the heart fails to contract normally, while in diastolic heart failure, the muscles in the left ventricle become stiff. Common symptoms of heart failure include fatigue, swelling at the ankles, feet, and legs, weight gain, and increased urge to urinate. Heart failure has significant burden on the global health care system, affecting more than 26 million people across the globe. It is estimated that heart failure across the globe had cost around US$ 100 Bn in 2012. Read Report Overview: https://www.transparencymarketresearch.com/heart-failure-therapeutics-market.html The global heart failure therapeutics market is estimated to be primarily driven by high incidence rate of heart failure disorders across the globe. Around 5 million Americans are estimated to be currently living with congestive heart failure and more than 5.5 million new cases are diagnosed every year in the U.S. Also, heart failure cases account for 11 million visits to physicians every year in the U.S. and higher number of hospitalization than that of all forms of cancer combined together. Moreover, adoption of western lifestyle, lack of physical exercise, daily life stress, unhealthy diet, and high prevalence of obesity are the key causes leading to heart failure. These factors are projected to fuel the growth of the global heart failure therapeutics market during the forecast period. Rise in trend of new product development and commercialization among the leading players operating in the global market has been observed since the past few years. Increase in demand and easy availability of heart failure therapeutics drugs are estimated to drive the growth of the market during the forecast period. The global heart failure therapeutics market can be segmented based on heart failure stage, drug class, distribution channel, and region. In terms of heart failure stage, the market can be classified into class I, Class II, Class III, and Class IV. Based on drug class, the market can be divided into Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Diuretics, Beta Blockers, Procoralan, Mineralocorticoid Receptor Antagonists, and others. Angiotensin-converting enzyme (ACE) inhibitors are a group of medication used for dilation or widening of heart blood vessels to facilitate the free flow of blood to the heart and to lower the blood pressure. Most commonly used ACE inhibitors include Accupril, Aceon, Altace, Capoten, Lotensin, Mavik and Monopril. ACE inhibitors are generally prescribed for management of high blood pressure, heart failure, coronary artery diseases, diabetes, and other cardiovascular disorders. The ACE inhibitors segment is projected to dominate global heart failure treatment market by the end of 2026, expanding at a significant CAGR during the forecast period. In terms of distribution channel, the market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is poised to hold prominent share of the market by the end of 2026. In terms of region, the global heart failure therapeutics market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are estimated to account for a dominant share of the global market, owing to high prevalence and rise in incidence rate of heart failure, large base of pharmaceutical companies, high awareness level, well-established health care facilities, and favorable medical reimbursement policies in these regions. Moreover, rapidly increasing geriatric population which is more prone to suffer from heart failure in countries such as the U.S., the U.K., Germany, and France is likely to contribute to major market share of these regions by the end of 2026. The heart failure therapeutics market in Asia Pacific is projected to grow rapidly during the forecast period, owing to large pool of patients affected with heart failure in highly populous countries such as India and China, large base of geriatric population in Japan, and rapidly changing health care sector in the emerging countries. Increase in per capita health care expenditure, rapidly growing biopharmaceutical industry, and various initiatives taken by the government in the emerging countries to promote health care are estimated to fuel the growth of the heart failure therapeutics market in Asia Pacific during the forecast period. The heart failure therapeutics market in Latin America and Middle East & Africa is projected to grow at a moderate rate during the forecast period. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53994 The global heart failure therapeutics market is highly fragmented. A large number of manufacturers holds prominent market share in respective regions. A key trend of mergers and acquisitions and new product development among the leading players has been observed since the past few years. Companies are engaging in mergers and acquisitions in to order to strengthen their product portfolio and enhance their geographic presence in respective regions. Key players operating in the global heart failure therapeutics market include Amgen Inc., Pfizer Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Abbott, Bayer AG, Orion Corporation, Merck & Co. Inc., and Cardiorentis Ag. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Mirah Belle Naturals Company Releases Coupon Code for Discount on Its Products - Mirah Belle Natural Company has released a coupon code for buying discount on products from Retail Pharma online store. Mirah Belle Natural Company today announced that its customers can use a special coupon code, 'MBN20', to get a fabulous 20% discount on order above Rs. 200 any Mirah Belle product at Retail Pharma India. All people need to do is visit the site Retail Pharma India and buy Mirah Belle Products and find the best offered deals for shopping purposes. Retailpharmaindia.com, where you’ll get to pick from the best brand names in fragrances, cosmetics, skin care, bath and body, hair care, accessories. You can shop by brand or browse by product category and get the special Discounts, Promo codes, Promotional codes, Coupon Codes. Mirah Belle Naturals is dedicated to creating the Best Quality, Healthy and Effective Skin and Hair care products that will Nourish your Skin and Infuse it with Natural Ingredients. A product is only as good as the ingredients used to make it. We always use the best ingredients to make the best safe and effective skin and hair care products. Natural products are the way to go in future, and we strive to serve you with exactly those! Our Singular motto is to use the power and simplicity of nature to cleanse, soothe, heal and protect your skin. Why Buy Natural & Organic Skin Care *You will look 10 years younger *Your wrinkles will disappear *Your skin will look like that of a super model *Your skin will become youthful and firm Sadly, this is what many commercial skin care companies are selling—the secret to perfect skin and eternal youth. No skin care product, whether natural, organic or conventional can "cure" aging. Aging is a fact of life, not a condition that needs to be (or can be) cured by skin care products. About Retail Pharma India Company: Retail Pharma India is a leading Online Pharmacy Store and information site for health, beauty, wellness, personal care, and pharmacy products. Our online store provides a convenient, private, and informative shopping experience that encourages consumers to buy products essential to healthy everyday living. To know more, log on to https://www.retailpharmaindia.com/ Join us on Facebook: https://www.facebook.com/RetailPharmaOfficial/ Follow us on Twitter: https://twitter.com/retailpharma1 (Added: Mon Jan 07 2019 Hits: 5 Rating: 0.00 Votes: 0) Rate It

• Mirah Belle Naturals Company Releases Coupon Code for Discount on Its Products - Mirah Belle Natural Company has released a coupon code for buying discount on products from Retail Pharma online store. Mirah Belle Natural Company today announced that its customers can use a special coupon code, 'MBN20', to get a fabulous 20% discount on order above Rs. 200 any Mirah Belle product at Retail Pharma India. All people need to do is visit the site Retail Pharma India and buy Mirah Belle Products and find the best offered deals for shopping purposes. Retailpharmaindia.com, where you’ll get to pick from the best brand names in fragrances, cosmetics, skin care, bath and body, hair care, accessories. You can shop by brand or browse by product category and get the special Discounts, Promo codes, Promotional codes, Coupon Codes. Mirah Belle Naturals is dedicated to creating the Best Quality, Healthy and Effective Skin and Hair care products that will Nourish your Skin and Infuse it with Natural Ingredients. A product is only as good as the ingredients used to make it. We always use the best ingredients to make the best safe and effective skin and hair care products. Natural products are the way to go in future, and we strive to serve you with exactly those! Our Singular motto is to use the power and simplicity of nature to cleanse, soothe, heal and protect your skin. Why Buy Natural & Organic Skin Care *You will look 10 years younger *Your wrinkles will disappear *Your skin will look like that of a super model *Your skin will become youthful and firm Sadly, this is what many commercial skin care companies are selling—the secret to perfect skin and eternal youth. No skin care product, whether natural, organic or conventional can "cure" aging. Aging is a fact of life, not a condition that needs to be (or can be) cured by skin care products. About Retail Pharma India Company: Retail Pharma India is a leading Online Pharmacy Store and information site for health, beauty, wellness, personal care, and pharmacy products. Our online store provides a convenient, private, and informative shopping experience that encourages consumers to buy products essential to healthy everyday living. To know more, log on to https://www.retailpharmaindia.com/ Join us on Facebook: https://www.facebook.com/RetailPharmaOfficial/ Follow us on Twitter: https://twitter.com/retailpharma1 (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Mirah Belle Naturals Company Releases Coupon Code for Discount on Its Products - Mirah Belle Natural Company has released a coupon code for buying discount on products from Retail Pharma online store. Mirah Belle Natural Company today announced that its customers can use a special coupon code, 'MBN20', to get a fabulous 20% discount on order above Rs. 200 any Mirah Belle product at Retail Pharma India. All people need to do is visit the site Retail Pharma India and buy Mirah Belle Products and find the best offered deals for shopping purposes. Retailpharmaindia.com, where you’ll get to pick from the best brand names in fragrances, cosmetics, skin care, bath and body, hair care, accessories. You can shop by brand or browse by product category and get the special Discounts, Promo codes, Promotional codes, Coupon Codes. Mirah Belle Naturals is dedicated to creating the Best Quality, Healthy and Effective Skin and Hair care products that will Nourish your Skin and Infuse it with Natural Ingredients. A product is only as good as the ingredients used to make it. We always use the best ingredients to make the best safe and effective skin and hair care products. Natural products are the way to go in future, and we strive to serve you with exactly those! Our Singular motto is to use the power and simplicity of nature to cleanse, soothe, heal and protect your skin. Why Buy Natural & Organic Skin Care *You will look 10 years younger *Your wrinkles will disappear *Your skin will look like that of a super model *Your skin will become youthful and firm Sadly, this is what many commercial skin care companies are selling—the secret to perfect skin and eternal youth. No skin care product, whether natural, organic or conventional can "cure" aging. Aging is a fact of life, not a condition that needs to be (or can be) cured by skin care products. About Retail Pharma India Company: Retail Pharma India is a leading Online Pharmacy Store and information site for health, beauty, wellness, personal care, and pharmacy products. Our online store provides a convenient, private, and informative shopping experience that encourages consumers to buy products essential to healthy everyday living. To know more, log on to https://www.retailpharmaindia.com/ Join us on Facebook: https://www.facebook.com/RetailPharmaOfficial/ Follow us on Twitter: https://twitter.com/retailpharma1 (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Saline Laxatives Market Analysis and Demand with Future Forecast to 2026 - The drive for saline laxatives stems from the need for medications in triggering bowel movements in a variety of clinical and medical conditions. Saline laxatives fall under the group of hyperosmotic drugs and are used usually as a combination medication. They are popularly used in the treatment of occasional constipation. Various saline laxatives, such as sodium phosphate, are increasingly being demanded in clinical applications for clearing intestines of stool before certain surgical and bowel procedures, such as colonoscopy. Read Report Overview: https://www.transparencymarketresearch.com/saline-laxatives-market.html The dosage of saline laxatives in clinical applications depends on medical conditions, response to treatment, and age. For instance, their use may be restricted in patients suffering with cardiac or renal dysfunction. Sticking to proper guidelines by doctors and clinicians by patients taking saline laxatives is imperative to gain the desired outcomes. The growing risk of laxative dependence arising out of indiscriminate or medically unwarranted use of saline laxatives in individuals may be adversely hampering the prospects of the saline laxative market. The report on the global saline laxatives market offers insights into the key growth dynamics, promising drug formulations, emerging treatment paradigms supported by the demand for saline laxatives. The study takes a critical look at major drug development initiatives in the saline laxatives market. The prevalence of lifestyle-driven constipation among people, especially in developing economies, is a key trend bolstering the demand for saline laxatives. The prevalence is compounded by growing trend of sedentary lifestyles, thereby propelling the growth of the market. The rising consumption of low-fiber diet by various global populations is a key factor driving the demand for saline laxatives. Over the past few years, the medical burden of chronic constipation has increased, especially in elderly populations. Coupled with this, rapid advances in therapeutics in understanding the epidemiology and management of the conditions is bolstering the expansion of the market. The rising instance of self-recognition of constipation in developing and developed countries in various regions is also fueling the demand for saline laxatives as occasional constipation relievers. Furthermore, the growing use of saline laxatives among geriatrics is also helping the opportunities in the market to rise rapidly. However, the growing incidence of laxative abuse in various patient populations is a glaring constraint hampering the growth of the saline laxatives market. The abuse can affect the functioning of kidneys and heart and may lead to serious dysfunction of bowel motility in individuals taking saline laxatives. On the geographical front, developed regions may present large potential in saline laxatives market. For instance, North America is expected to offer substantial avenues for several players in the saline laxative market. This can be attributed mainly to the rising demand for saline laxatives in emergency care and surgical procedures in hospitals and clinics to clear stool in patients. The Europe market for saline laxatives is also anticipated to make large strides, driven from the growing uptake of prescribed saline laxatives in patient populations. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54537 The report on the global saline laxatives market takes a critical look at the prevailing strategic dynamic among incumbent players and new entrants. The study also offers insights into those strategies that are likely to significantly alter the competitive landscape in the near future. Some of the key players in the saline laxatives market are Walgreen Co., The Kroger Company, Supervalu Inc., Safeway Inc., Salix Pharmaceuticals, C.B. Fleet Company, Inc., and Bayer AG. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Image-guided Therapy Systems Market to Witness Considerable Upsurge During 2018-2026 - The report details an exhaustive account of the global airway management devices market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2028. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global airway management devices market, as well for those who intend to newly establish themselves in this environment. Read Report Overview: https://www.transparencymarketresearch.com/airway-management-devices-market.html With increasing urbanization and rising disposable income, many people are making use of airline services, primarily driving the global airway management devices market. Moreover, several airlines are pouring humungous investments to develop their organizations from qualitative perspective. This is consequently increasing the demand for necessary devices needed to facilitate effective management, thereby proving to be a boon to the market. Increasing tourism all over the world has caused a surge in the need for quality management of aircraft services, thereby propelling splendid progress in the global airway management devices market. To manage a vast mode of transport that needs greater care than any other transportation type, a great need of monitoring all associated processes properly exists. Such a need can be fulfilled by using quality airway management devices, consequently providing an extensive push to the airway management devices market and make it expand at a vigorous pace. Region-wise, this market is spread across North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Of these, a strong tourism and transportation-based infrastructure in North America has made this region hold a leading stance with maximum shares in the global airway management devices market in recent times. However, numerous players are expanding their geographical reach in Asia Pacific too, thus giving causing new airlines to get established in this region on a frequent basis. This has made Asia Pacific record an unprecedented growth in recent times in the global airway management devices market, consequently making it expand at a ferocious pace in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54603 This market depicts the presence of a highly competitive vendor landscape mainly due to the lucrative nature of the airline and aircraft industry. The competition is gradually expanding and is anticipated to proliferate to the remotest regions during the next few years in the global airway management devices market. Participating in mergers & acquisitions, expansion of service portfolios, and achieving product and service differentiation are key schemes implemented by most businesses operating in this sector. Medtronic, Smiths Medical, Teleflex, Ambu, KARL STORZ, Flexicare, Verathon, Olympus, Intersurgical, SunMed, Vyaire Medical, and VBM Medizintechnik, are key players operating in the global airway management devices market. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 6 Rating: 0.00 Votes: 0) Rate It

• Fatigued at the end of the day? Blame your posture - According to a recent study, poor posture while working on the computer can lead to fatigue, increased muscle tension, and even injury to the vertebrae over time. The seemingly harmless posture can even limit the ability to turn your head. When the head juts forward at a 45-degree angle, the neck acts like a fulcrum, like a long lever lifting a heavy object. However, with a tall and erect posture, the back muscles can easily support the weight of one’s head and neck. People who suffer from headaches or neck and backaches from computer work must check their posture. It is imperative to ensure that the head is aligned on top of the neck, as if held by an invisible thread from the ceiling. Speaking about this, Padma Shri Awardee, Dr KK Aggarwal, President, HCFI, said, “Postural dysfunction or “poor” posture is one where the spine is positioned in unnatural positions. The curves are emphasized which puts stress on the joints, muscles, and vertebrae. This prolonged poor positioning leads to a build-up of pressure on these tissues. Although physiotherapy can help solve this problem, it is important to correct one’s posture at the outset. Sitting for a long time in the same position can put pressure on the back muscles and spinal discs. Further, slouching can over-stretch the spinal ligaments and strain the spinal discs causing major pain in the back and neck. Prolonged standing also has its own health implications. Keeping the body upright needs a lot of muscular effort. Standing for a long time leads to pooling of blood in the legs and reduces active circulation of blood. This accelerates the onset of fatigue causing pain in the leg, back, and neck muscles.” Some symptoms of back and spine problems include weight loss, elevated body temperature (fever), inflammation (swelling) on the back, pain down the legs and below the knees, urinary incontinence, difficulty in urinating, fecal incontinence, and numbness around the genitals. Adding further, Dr Aggarwal, who is also the Group Editor-in-Chief of IJCP, said, “Apart from wrong posture at work, prolonged use of mobile phones is another major cause of spinal problems today. Keeping the right amount of curvature in the back takes pressure off the nerves and will reduce back pain. If you experience fatigue or pain when you wake up in the morning or after you’ve been sitting at your desk for a couple of hours, it may be an indication that your posture is not right.” Some tips from HCFI · Get moving. Physical activity helps in keeping the joints fluid. A person who is not physically active is more susceptible to back problems. · Eat healthy. If you maintain good eating habits, you not only will maintain a healthy weight, but you also will not put unnecessary stress on your body. · Sleep sideways. The best position for sleeping is on your side. If you are sleeping on your stomach, put a pillow under your lower abdomen to help take stress off your back. · Correct your posture and avoid stress. The importance of good posture cannot be overlooked in preventing back problems. Additionally, stress can tense your muscles, and constant tension of this kind can cause back pain. Thus, it is important to find ways to reduce stress. (Added: Mon Jan 07 2019 Hits: 9 Rating: 0.00 Votes: 0) Rate It

• Airway Management Devices Market Explores New Growth Opportunities by Leading Manufacturers - The report details an exhaustive account of the global airway management devices market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2028. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global airway management devices market, as well for those who intend to newly establish themselves in this environment. Read Report Overview: https://www.transparencymarketresearch.com/airway-management-devices-market.html With increasing urbanization and rising disposable income, many people are making use of airline services, primarily driving the global airway management devices market. Moreover, several airlines are pouring humungous investments to develop their organizations from qualitative perspective. This is consequently increasing the demand for necessary devices needed to facilitate effective management, thereby proving to be a boon to the market. Increasing tourism all over the world has caused a surge in the need for quality management of aircraft services, thereby propelling splendid progress in the global airway management devices market. To manage a vast mode of transport that needs greater care than any other transportation type, a great need of monitoring all associated processes properly exists. Such a need can be fulfilled by using quality airway management devices, consequently providing an extensive push to the airway management devices market and make it expand at a vigorous pace. Region-wise, this market is spread across North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Of these, a strong tourism and transportation-based infrastructure in North America has made this region hold a leading stance with maximum shares in the global airway management devices market in recent times. However, numerous players are expanding their geographical reach in Asia Pacific too, thus giving causing new airlines to get established in this region on a frequent basis. This has made Asia Pacific record an unprecedented growth in recent times in the global airway management devices market, consequently making it expand at a ferocious pace in the region. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54603 This market depicts the presence of a highly competitive vendor landscape mainly due to the lucrative nature of the airline and aircraft industry. The competition is gradually expanding and is anticipated to proliferate to the remotest regions during the next few years in the global airway management devices market. Participating in mergers & acquisitions, expansion of service portfolios, and achieving product and service differentiation are key schemes implemented by most businesses operating in this sector. Medtronic, Smiths Medical, Teleflex, Ambu, KARL STORZ, Flexicare, Verathon, Olympus, Intersurgical, SunMed, Vyaire Medical, and VBM Medizintechnik, are key players operating in the global airway management devices market. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Nephrotic Syndrome Market Inclined to Deliver Positive Growth Results until 2026 - Nephrotic syndrome is a kidney disorder defined by collection of symptoms such as proteinuria, hyperlipidemia, hypoalbuminia, edema, and various other complications. It develops following a pathological injury caused to the renal glomeruli, which damages the basement membrane in the renal glomeruli. The renal glomeruli filter waste and excess water from the blood. Risk factors for nephrotic syndrome may be a primary cause, with the disease being specific to the kidneys. Secondary factors include hepatitis C, diabetes, malaria, systemic lupus, HIV, hepatitis B, congenital infections, or abuse of certain drugs. Read Report Overview: https://www.transparencymarketresearch.com/nephrotic-syndrome-market.html Factors driving the global nephrotic syndrome market include increasing incidence and prevalence of nephrotic syndrome worldwide, growing elderly population, high rate of incidence hyperlipidemia, and increasing number of individuals suffering from diabetes. Moreover, other complications such as thromboembolism, HIV, hepatitis B, and hepatitis C also contribute toward the increasing rate of incidence and prevalence of nephrotic syndrome worldwide. The market for nephrotic syndrome is primarily driven by presence of a large patient pool suffering from nephrotic syndrome. According to the WHO, more than 1.4 million people worldwide undergo renal replacement therapy every year, with the rate of incidence of chronic kidney disease (CKD) rising by approximately 8% annually. However, increase in the health care expenditure and stringent regulatory approvals are likely to be restraining factors for the nephrotic syndrome market in the near future. The global nephrotic syndrome market can be segmented based on drug, and geography. In terms of drug, the market can be classified into sodium restriction drugs, fluid restriction drugs, loop diuretics, angiotensin-converting enzyme inhibitor (or angiotensin receptor blocker therapy), and others. The pipeline of drugs for nephrotic syndrome is relatively small with a total of around 10 products undergoing active development in companies/institutes/universities. Of the 10 pipeline products, mostly acting on the cause effect of nephrotic syndrome, meaning they act on molecular targets not yet present in any market in the pharmaceutical industry, that are expected to become blockbuster drugs for the indication during the forecast period, generating further market growth within the nephrotic syndrome market. Geographically, the global nephropathic syndrome market can be categorized into five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a major share of the global nephrotic syndrome market in 2017. Increase in the prevalence of nephrotic syndrome among infants, rise in funding for research, and growth in awareness about effects of the disease are likely to drive the nephrotic syndrome market in North America during the forecast period. The National Institutes of Health Office of Rare Diseases and the National Institutes of Diabetes, Digestive & Kidney Diseases have renewed the second 5-year funding cycle of the Nephrotic Syndrome Study Network, known as NEPTUNE, by offering a grant of US$ 5.8 Mn to the University of Michigan. The University of Michigan is contributing US$ 4.2 Mn over a 5-year period. Europe and Asia Pacific are projected to gain market share during the forecast period. These regions are likely to account for a significant share of the global market, in terms of revenue, in the near future. Initiatives by local governments to attain self-sufficiency in the production of pharmaceuticals and financial support for research and development of drugs for nephrotic syndrome in countries such as Brazil and South Africa are likely to boost the market in Latin America and Middle East & Africa throughout the forecast period. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54780 Major players operating in the global nephrotic syndrome market are Asahi Kasei Pharma Corp, Bristol-Myers Squibb Co, Orbis Biosciences Inc., Aurinia Pharmaceuticals Inc., Pfizer Inc., Mallinckrodt LLC, Novartis AG and Retrophin, Inc. Companies are adopting organic and inorganic growth strategies to expand their product offerings; enhance their geographical reach; expand their customer base; and gain market share. In 2014, Anthera Pharmaceuticals, Inc. and Zenyaku Kogyo Co., Ltd. entered into an exclusive licensing agreement for development and commercialization of subcutaneous blisibimod in Japan and other countries across Asia. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• FUE Hair Transplant Clinics | Best Hair Transplant Doctors | Hair Growth Treatment - Origin clinic is one of the leading hair growth clinics in Hyderabad and we have the best hair transplant doctors and best hair transplant surgeons practicing at Origin clinic. Trichologists at the Origin clinic are experts in hair transplantation in hyderabad and hair fall treatment in Hyderabad etc. We are one of the best hair transplantation clinics in Hyderabad. Today, advanced hair transplantation procedures have become affordable and reliable. Thanks to technology and the expertise of a hair specialist, a hair transplant only takes a few hours or half a day, which depends on the severity of hair loss. Hair loss is a condition that needs immediate attention, both for medical and aesthetic reasons. One of the most successful and reliable procedures to restore and refine hair is a FUE hair transplant in hyderabad. Hair transplants are helping patients regain their confidence and hair. Our hair specialists at Origin clinic will walk you through the entire process, so there’s nothing to worry about before and after the procedure. Hair transplant results, however, take some time before the hair reaches it prime. We know no one enjoys the wait, but this wait is worth the while. So, patience is key. Your hair is in good hands at Origin clinic. A best hair fall solution can be a good care for your damaged hair. The hair loss prevention in Hyderabad given by origin clinic includes hair loss treatment for women, hair restoration treatment and hair growth treatment. (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Fertility and Pregnancy Rapid Test Kits Market - Global demand for fertility and pregnancy rapid test kits market will reach US$ 1,068.4 Mn in 2016, up from US$ 1,029.1 Mn in 2015, witnessing 3.8% growth in 2016 over 2015. Increasing prevalence of gynaecological diseases and infertility will continue to drive demand in 2016, with dual-capability test kits gaining traction among consumers. Pregnancy rapid test kits will continue to witness higher demand than fertility kits, representing US$ 600 Mn in market value in 2016. Line-indicator kits will continue to outsell digital devices, with the latter generating only one-third revenues of the former. Mid-stream and cassettes line indicator pregnancy rapid test kits will witness strong growth rates than strips/dip sticks, however, strips/dip sticks will continue to account for the highest market value, representing US$ 197 Mn in revenues in 2016. Line indicators will remain the preferred product type in fertility rapid test landscape as well, representing market value worth US$ 329.2 Mn in 2016, up from US$ 317.7 Mn in 2015. hCG urine test will account for the highest market share on the basis of test type, representing nearly 43% revenue share in 2016. Apart from hCG, other test types – FSH urine test, hCG blood test, and LH urine test will witness a decline in their market share, suggesting increasing preference for conventional laboratory tests. Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-607 Drugstores and pharmacies will remain the largest distribution channels for both fertility and pregnancy rapid test kits. Drugstores will sell US$ 286.4 Mn worth of fertility and pregnancy rapid tests kits in 2016, representing nearly 27% revenue share of the market by distribution channel. North America will remain the largest market for fertility and rapid test kits in 2016, accounting for over half of global revenues. Demand for rapid kits will continue to grow in the developing countries of Asia Pacific, Middle East, and Africa. While APEJ fertility and rapid test kits market will reach US$ 267.2 Mn in revenues in 2016, MEA market will be worth US$ 7.5 Mn. Market Segmentation By Product Based on product type, the market has been segmented into pregnancy rapid test kits and fertility rapid test kits. Pregnancy rapid test kits product type segment is further classified as line-indicator devices (further sub-segmented into strip/dip sticks, mid-stream devices and cassettes) and digital devices, whereas, fertility rapid test kits product type segment consists of line-indicator devices and digital devices. In terms of value, pregnancy test kits segment is estimated to account for more than 55% market share in global fertility and pregnancy rapid test kits market, by 2026 end. Market Segmentation By Test Type On the basis of test type, the market has been segmented into LH urine test, FSH urine test, hCG blood test and hCG urine test. hCG urine test segment accounted for highest market share of 42.8% in 2015 and is expected to gain the market share over the forecast period. Increasing demand for hCG rapid test is attributed to rising incidence of gynaecological disorders and infertility rate across the globe. Market Segmentation By Distribution Channels On the basis of distribution channels, the market has been segmented into pharmacies, drugstores, gynaecology and fertility clinics, online sales and hypermarkets & supermarkets. Drugstores followed by pharmacies are the most preferred medium of distribution of fertility and pregnancy rapid test kits. However, increasing consumer preference for online sales channel which provides mail order requests, are expected to impart significant competition to these traditional channels in some of the regions such as North America and Western Europe. Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-607 Church & Dwight Co., Inc., Alere Inc., bioMérieux SA, and Quidel Corporation are the market leaders in the global fertility and pregnancy rapid test kits landscape. Collaboration with distribution partners and strengthening market position through acquisitions remains the key strategy of these players. Long-term Outlook: Future Market Insights projects a moderate 4.1% CAGR for fertility and pregnancy rapid test kits market during the forecast period 2016-2026. (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Stress Management Conference - On behalf of Organizing Committee we tend to invite all the participants from all a part of the globe to attend the strain conference entitled “6th International Conference on Depression, Anxiety and Stress Management” on April 25-26, 2019 at London, UK. Stress 2019 is that the leading meeting dedicated to Psychiatrists and Stress researchers with the theme “A Positive step for a brand new starting towards Stress, Depression & Anxiety” Goal of Stress 2019 is to deliver an impressive program for exchange of concepts and authoritative views by leading scientists that covers the whole spectrum of analysis in Stress, Anxiety, and Depression and share the society experiences of assorted treatment procedures. Stress 2019 is Associate in society of Psychiatrists likewise as Stress committees to debate the long run of the strain and psychological medicine in terms of collaboration, structures and structure development and advances of Stress and Psychological syndromes. To view our official Website click here: https://stressmanagement.psychiatrycongress.com/ According to UNISON numbers, 27 million people suffer from depression all over Europe. And it is the second commonest reason for incapacity to figure. The EU Commission estimates that UNISON economies face £134 billion in annual prices because of this burden. Why to attend? 6th International Conference on Depression, Anxiety and Stress Management may be a distinctive forum to assemble worldwide distinguished lecturers within the field of psychological science and psychological medicine, Stress researchers, public health professionals, scientists, tutorial scientists, business researchers, students to exchange regarding state of the art analysis and technologies. The Conference can feature several exciting tutorial programs together with multiple panels, workshops, affinity cluster lunches, paper displays, and scientific sessions by putative psychiatrists from everywhere the country. Online Abstract submission link: https://stressmanagement.psychiatrycongress.com/abstract-submission.php Online Abstract submission link: https://stressmanagement.psychiatrycongress.com/ Best regards, Shira Decruz Program Manager: Stress 2019 47 Churchfield Road, W3 6AY, London, UK T: +44-800-014-8923, +1 702 508 5192 Ext 8057 E: stress@conferencesfinder.com (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Global Active Pharmaceutical Ingredient Market Detailed Research Survey 2019-2025 - Worldwide Active Pharmaceutical Ingredient Market Report covers the present scenario and the growth prospects of the Active Pharmaceutical Ingredient industry for 2019-2025. To calculate the market size, the report considers the revenue generated from the sales of Active Pharmaceutical Ingredient globally. Active Pharmaceutical Ingredient Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The Active Pharmaceutical Ingredient report covers the market background and its growth foresight over the up-coming years and review of the key merchants effective in this market. The report enlightens minute analysis of Active Pharmaceutical Ingredient market grounded on regions and active market performers additionally it offers CAGR estimations for the period 2019 to 2025 that help readers to comprehend the futuristic approach of Active Pharmaceutical Ingredient on a global level. Get Sample PDF Copy of Active Pharmaceutical Ingredient Market Research Report@ http://marketdesk.us/report/global-active-pharmaceutical-ingredient-market-2017-99s/1762/#requestForSample This Market Analysis Report Covers  A. SWOT Analysis (Strengths, Weaknesses, Opportunities, and Threats) B. PESTEL Analysis (Political, Economic, Socio-cultural and technological) C. Porter's Five Forces (analyzing competition of a business) D. Six-Segment Analysis. E. VRIO (Value, Rareness, Imitability, Organization) Analysis. F. Upstream and Downstream Analysis. Global Active Pharmaceutical Ingredient Market analyzes on key Active Pharmaceutical Ingredient manufacturers and study the capacity, market share, production, value, and development plans for the next few years. It also focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, and SWOT analysis. It also defines, describes and forecast the market by various types, applications and by regions. Later, this report also encourages you to understand factors driving or inhibiting the market growth along with each submarket with respect to individual growth trend and their contribution to the market. In the end, this report provides details of competitive developments such as contracts, developments, product launches, and acquisitions in the market. Global Active Pharmaceutical Ingredient Market Details Based On Key Players: Teva, Novartis, Pfizer, Johnson & Johnson, North China Pharmaceutical Group, North China Pharmaceutical Group, Dr. Reddy?s Laboratories, Roche, Aurobindo pharma, Sun Pharmaceutical Industries, Boehringer Ingelheim GmbH, Bayer, BASF, DSM, Zhejiang Medicine, Biocon, Johnson Matthey, Hisun Pharmacy, Cambrex, Shandong Xinhua Pharmaceutical, Lonza group, Huahai Pharmaceutical, Haerbin Pharmaceutical Group, Cipla, Tian Yao, Lupin, North East Pharmaceutical, Albemarle, Shandong Lukang Pharmaceutical, Jiangsu Hengrui Medicine, Bachem etc. Inquiry Here For Detail Report @ http://marketdesk.us/report/global-active-pharmaceutical-ingredient-market-2017-99s/1762/#inquiry Active Pharmaceutical Ingredient Market Research Report Covers Key Region (with Regional Output, Demand & Forecast by Countries): North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Russia, Spain etc.), Asia-Pacific (China, India, Japan, Southeast Asia etc.), South America (Brazil, Argentina etc.), Middle East & Africa (Saudi Arabia, South Africa etc.). Active Pharmaceutical Ingredient Market Based On Product Type: Type1,Type2,Type3 Active Pharmaceutical Ingredient Market Based On Product Applications: Application1,Application2,Application3 Intended Audience:- ** Active Pharmaceutical Ingredient manufacturers ** Traders and distributors of Active Pharmaceutical Ingredients ** Research and development institutes ** Potential investors ** Raw material suppliers ** Nationalized laboratories Get the Overview of TOC, What It Contains? – Overview of Active Pharmaceutical Ingredient Market, Competitions by (Players, Types, Applications), Players Profiles, Imports/Exports Market Analysis, and Sales Data, Production Market Analysis by Regions, Sales Market Analysis by Region, Upstream and Downstream Analysis, Active Pharmaceutical Ingredient Market Forecast (2019-2025), And More. Through the statistical analysis, the report delineates the global Active Pharmaceutical Ingredient market including production, capacity, cost/profit, supply/demand, production value, and import/export. The total market is further isolated by the organization, by application/type, and by country for the aggressive landscape analysis. Towards the end, The Market contemplate gives information with n-number of tables and figures examining the Active Pharmaceutical Ingredient, the exploration gives you a visual, one-stop breakdown of the submarkets, leading products and market. In conclusion, it is a deep research report on Global Active Pharmaceutical Ingredient industry.it gives the brightening about the disclosures of the Active Pharmaceutical Ingredient market research, data origination, auxiliary and conclusion. Browse Detailed TOC, Tables, Figures, Charts and Companies Here @ http://marketdesk.us/report/global-active-pharmaceutical-ingredient-market-2017-99s/1762/#toc (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• World Neonatology and Child Care Meeting - Europe Conferences is glad to announce “Neonatology Meeting 2019” on September 16-17, 2019 Paris, France. The conference is working under the theme “Neonatology Meeting 2019: Promoting the New Innovative Thoughts in Neonatology Research” Neonatology Meeting main objective is to discuss about the recent on-going neonatal research and how it can benefit mankind This is going to be accomplished by the speakers and professors of varied demographics who are going to put forward their perception and research on the very topic. Target Audience: Neonatology Meeting 2019 target the young researchers; Neonatologists, Physicians, Pediatricians, Pediatric surgeons, Pediatric surgeons, Health Care Professionals, nurses, Professors from academic and we also target the Delegates from Pharmacists companies, where in we will collectively highlight the major issues related Neonatology and Pediatrics (Added: Mon Jan 07 2019 Hits: 5 Rating: 0.00 Votes: 0) Rate It

• Effective IHC Troubleshooting Tips - Booster Antibody and ELISA Experts - Immunohistochemistry or IHC is a process wherein antibodies are used to discover an antigen in sectioned tissue and is ubiquitous in the research, preclinical, and medical settings for visualizing cell additives. The steps for executing Immunohistochemistry and the various tools and reagents have remained comparatively unchanged for decades. But, grasping the primary steps in a simple IHC protocol is not any assurance of regular, interpretable images. Optimization and best-tuning are the keys to success in growing an IHC protocol for a brand new target. • The steps of an effective IHC protocol are simple: • Specimen Preparation • Antigen Retrieval • Blocking • Primary Antibody Staining • Detection Let’ find out the IHC Troubleshooting Tips to improve your IHC data given by Booster Antibody and ELISA experts: Tip #1 Make sure to use highly cross-adsorbed secondary antibodies It should be noted that secondary antibodies should be used in fairly high concentrations in IHC, with the risk of binding non-specifically to tissue components majoring to high background. With an intention to decline cross-reactivity, it will be best suited to use massive cross-adsorbed secondary antibodies. In addition, with a purpose to examine specificity, the users may test the secondary antibodies in the absence or lack of primary antibodies. In a case, if performing IF, then make sure to take into considering of autofluorescent molecules that may be contained in tissues. Moreover, make sure to restrict the use of directly conjugated antibodies only for those target proteins which are very ample in the cell. The user can access a wide range of validated secondary antibodies with this dedicated Secondary Antibody search engine. Tip #2 Make sure to use positive and negative controls to check primary antibody particularity It should be noted that primary antibodies can fail to find out their target antigen for different reasons. Antibodies can bind non-specifically to other targets components. There are some ways to find out the specificity of the antibody, despite from checking in its datasheet that its use has been accepted for the particular Immunohistochemistry method to be used either frozen or FFPE (Formalin-Fixed Paraffin-Embedded), comprise the performance of negative controls and find out the optimal dilution. Tip #3 Make sure to indulge in entire tissue preparation Relative to antibody specificity, the way to put together the tissue analyzed additionally impacts experimental effects, even when the use of massive particular and well-characterized antibodies. Moreover, these results rise up mainly from epitope masking because of fixation-induced conformational modifications and failure of the antibody to penetrate the tissue. Moreover, tissue samples can be fixed or frozen: 1. Fixed and embedded tissue is a higher alternative for lengthy-term storage. 2. Freezing the sections basically continues the confirmation of the target antigen endowing advanced antibody binding. But small crystals of ice render these sections for prolonged storage. Moreover, antigens can be masked because of the fixation process. The unmasking can be done with epitope antigen unmasking, which is either mediated by heat or proteases. Furthermore, heat-induced epitope retrieval is more often used. Booster Antibody and ELISA experts is a prominent destination where you can get more guidance on IHC Embedding Optimization. For this, click on the official URL of https://immunostaining.info/. Address: 3942 Valley Ave Pleasanton, CA 94566, USA Email:support@bosterbio.com Phone: (888) 466-3604 (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Vascular Closure Devices Market is poised to cross USD 1063.64 Million in 2023 - Global Vascular Closure Devices Market- Medtronic to Acquire Neutrino Health Recent Developments Medtronic is a medical device company; it is one among the world’s largest medical equipment development companies. FDA approved the company’s new synchronised II myPTM, which assists the patients to monitor their pain and can set doses based on the pain. It is known as Medtronic pump, is indicated for patients with chronic pain. Medtronic had launched beacon heart failure management service, designed to monitor data from cardiac pacing devices to improve early interventions before heart failure events. Medtronic’s acquisition of Mazor strengthens Medtronic’s position as a global leader in enabling technologies for heart surgeries, and drives Mazor Robotics; vision to bring its core technology to the forefront of the global market To know more read: https://www.marketdataforecast.com/market-reports/vascular-closure-devices-market-3536/ Market Segmentation Market Data Forecast published a report named Global Vascular Closure DevicesMarket itis currently valued USD 754.83 Million in 2018 and it is expected to reach USD 1063.64 Million by 2023 at a CAGR of 7.1%. The report is segmented by Type · Passive Approximates · Active Approximates · External homeostatic devices Access · Femoral Access · Radial Access Procedure · Interventional cardiology · Interventional Radiology Surgery Active approximators segment is projected to hold the largest share in the VCDs market due to their high efficiency. Femoral access holds the largest market share because it is largely adopted by physicians around the globe. Acute care facilities are the largest market segment due to the increase of emergency cases in cardiovascular diseases. Geographical Segmentation: Based on region, the global vascular closure devices market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. North America is the largest market segment due to the increased cardiovascular diseases and the rising number of research activities and clinical trials for VCDs. Asia-Pacific is the fastest growing market segment with a huge patient base providing huge opportunities for the market players. Key market players in the market are - Merit Medical Systems Biotronik GMBH&Co Abbott Vascular Cardinal Health Medtronic View a sample and decide: https://www.marketdataforecast.com/market-reports/vascular-closure-devices-market-3536/request-sample The scope of the report: The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated. The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity. What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions. Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626 (Added: Mon Jan 07 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Fat Cutter Amla Juice for Weight Loss in India by Sharrets Nutrition - For Immediate Release Sharrets Nutrition LLP www.sharrets.in 3rd January 2019, Amla juice aids in benefiting which comprise maintaining proper health of the urinary tract and eliminating any mild contagions in that area that may be shown if you feel any burning while urinating. It helps to promotes healthy conditions in the kidneys and even will avoid in many cases the formation of kidney stones. The amla juice is very useful for various health problems which include stomach problem amla gooseberry juice is useful for stomach problems, not only for conditions of over acidity from mixing foods that don't agree or just too many rich or processed foods. Just a small amount, less than an ounce, mixed into your favorite fruit juice to counteract the bitter taste, will do wonders to relieve your upset stomach. The amla juice helps to control the balance of stomach intestinal emissions to prevent further stomach over acidity, and even upholds the right fascination of nutrients as they pass through the small intestine and the liver by regulating that the proper amount of bile is secreted for the breakdown of fats. As a beneficial side effect it can in many cases release the diarrhea as well. Externally when used on the hair, the gooseberry or amla juice encourages strong hair growth, actually improves the texture of the hair and strengthens the hair glands. By doing this there is less hair thinning even as you grow older. As a bonus the juice slows the early graying of the hair, allowing the hair to maintain its natural color. About Sharrets Nutrition LLP “SHARRETS” the brand develop to deliver only highest quality dietary health supplements and health foods at the best value. The company have a commitment and dedication to deliver best quality skincare, health, nutrition, supplements and dietary products at competitive price with quality promise. Offer compressive range of health products from vitamins and minerals, organic produces, sport nutrition to body and beauty supplement. (Added: Mon Jan 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... [>>]